Aprepitant
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
| - | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene=''> | + | <StructureSection load='' size='340' side='right' caption='Caption for this structure' scene='10/1020314/Cv/1'> |
Aprepitant, sold under the brand name Emend among others, is a medication used to prevent chemotherapy-induced nausea and vomiting (CINV) and to prevent postoperative nausea and vomiting (PONV).<ref name="a4">[https://www.drugs.com/monograph/aprepitant-fosaprepitant.html "Aprepitant/Fosaprepitant Dimeglumine Monograph for Professionals".] Drugs.com. Archived from the original on 13 August 2020. Retrieved 13 October 2019.</ref> See also [https://en.wikipedia.org/wiki/Aprepitant Aprepitant]. | Aprepitant, sold under the brand name Emend among others, is a medication used to prevent chemotherapy-induced nausea and vomiting (CINV) and to prevent postoperative nausea and vomiting (PONV).<ref name="a4">[https://www.drugs.com/monograph/aprepitant-fosaprepitant.html "Aprepitant/Fosaprepitant Dimeglumine Monograph for Professionals".] Drugs.com. Archived from the original on 13 August 2020. Retrieved 13 October 2019.</ref> See also [https://en.wikipedia.org/wiki/Aprepitant Aprepitant]. | ||
Revision as of 12:24, 24 December 2023
| |||||||||||
References
- ↑ "Aprepitant/Fosaprepitant Dimeglumine Monograph for Professionals". Drugs.com. Archived from the original on 13 August 2020. Retrieved 13 October 2019.
